Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1995 1
2006 2
2007 2
2008 2
2009 6
2010 11
2011 10
2012 2
2013 7
2014 10
2015 7
2016 6
2017 5
2018 4
2019 4
2020 10
2021 15
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design.
Marrouche NF, Greene T, Dean JM, Kholmovski EG, Boer LM, Mansour M, Calkins H, Marchlinski F, Wilber D, Hindricks G, Mahnkopf C, Jais P, Sanders P, Brachmann J, Bax J, Dagher L, Wazni O, Akoum N; DECAAF II Investigators. Marrouche NF, et al. Among authors: akoum n. J Cardiovasc Electrophysiol. 2021 Apr;32(4):916-924. doi: 10.1111/jce.14957. Epub 2021 Mar 2. J Cardiovasc Electrophysiol. 2021. PMID: 33600025 Clinical Trial.
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.
Marrouche NF, Wazni O, McGann C, Greene T, Dean JM, Dagher L, Kholmovski E, Mansour M, Marchlinski F, Wilber D, Hindricks G, Mahnkopf C, Wells D, Jais P, Sanders P, Brachmann J, Bax JJ, Morrison-de Boer L, Deneke T, Calkins H, Sohns C, Akoum N; DECAAF II Investigators. Marrouche NF, et al. Among authors: akoum n. JAMA. 2022 Jun 21;327(23):2296-2305. doi: 10.1001/jama.2022.8831. JAMA. 2022. PMID: 35727277 Clinical Trial.
Demystifying electrophysiology.
Hanna B, Akoum N. Hanna B, et al. Among authors: akoum n. Heart. 2022 Nov 24;108(24):1996-1997. doi: 10.1136/heartjnl-2022-321326. Heart. 2022. PMID: 36104220 No abstract available.
Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Marrouche NF, et al. Among authors: akoum n. JAMA. 2014 Feb 5;311(5):498-506. doi: 10.1001/jama.2014.3. JAMA. 2014. PMID: 24496537 Free article.
Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation.
Mahnkopf C, Kwon Y, Akoum N. Mahnkopf C, et al. Among authors: akoum n. Arrhythm Electrophysiol Rev. 2021 Dec;10(4):225-229. doi: 10.15420/aer.2021.51. Arrhythm Electrophysiol Rev. 2021. PMID: 35106172 Free PMC article. Review.
Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial.
Marrouche NF, Dagher L, Wazni O, Akoum N, Mansour M, El Hajjar AH, Bhatnagar A, Hua H; EDORA Investigators. Marrouche NF, et al. Among authors: akoum n. J Cardiovasc Electrophysiol. 2021 Dec;32(12):3203-3210. doi: 10.1111/jce.15274. Epub 2021 Nov 2. J Cardiovasc Electrophysiol. 2021. PMID: 34664772 Free PMC article. Clinical Trial.
95 results